US2006134147A1PendingUtilityA1
Cosmetic compositions having carnitine creatinate and methods for using
Est. expiryDec 21, 2024(expired)· nominal 20-yr term from priority
Inventors:Robert Kalafsky
A61K 8/44A61K 31/4166A61P 17/00A61Q 19/06A61Q 19/00A61K 8/4946A61Q 19/008
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is a topical composition having carnitine creatinate and a cosmetically acceptable vehicle. There is also provided a method for improving the aesthetic appearance of skin. There is also provided a method for inhibiting the induced lipid synthesis in skin. There is also provided a method for inhibiting the formation of cellulite in skin.
Claims
exact text as granted — not AI-modified1 . A topical composition, comprising:
carnitine creatinate; and a cosmetically acceptable vehicle.
2 . The composition of claim 1 , wherein the carnitine creatinate is present in an amount effective to improve the aesthetic appearance of skin.
3 . The composition of claim 1 , wherein the carnitine creatinate is present in an amount effective to inhibit induced lipid synthesis in skin.
4 . The composition of claim 1 , wherein the carnitine creatinate is present in an amount effective to inhibit cellulite formation in skin.
5 . The composition of claim 1 , wherein the carnitine creatinate is present at about 0.01 wt % to about 25 wt % based on the total weight of the composition.
6 . The composition of claim 1 , wherein the carnitine creatinate is present at about 0.05 wt % to about 10 wt % based on the total weight of the composition.
7 . The composition of claim 1 , wherein the carnitine creatinate is present at about 0.1 wt % to about 5 wt % based on the total weight of the composition.
8 . A method for improving the aesthetic appearance of skin, comprising: topically applying to the skin a composition having a cosmetically acceptable vehicle and an effective amount of carnitine creatinate.
9 . The method of claim 8 , wherein the carnitine creatinate is present at about 0.01 wt % to about 25 wt % based on the total weight of the composition.
10 . The method of claim 8 , wherein the carnitine creatinate is present at about 0.05 wt % to about 10 wt % based on the total weight of the composition.
11 . The method of claim 8 , wherein the carnitine creatinate is present at about 0.1 wt % to about 5 wt % based on the total weight of the composition.
12 . The method of claim 8 , wherein the vehicle has an adjuvant selected from the group consisting of one or more lower alcohols, fatty alcohols, fatty ethers, fatty esters, isododecane, polyols, glycols, liposomes, laminar lipid materials, water, and any combinations thereof.
13 . The method of claim 8 , wherein the composition is in the form of a product selected from the group consisting of aerosol spray, cream, lotion, gel, foam, ointment, mask, mousse, patch, powder, pump spray, stick, tape, towelette, patch, and pomade.
14 . The method of claim 8 , further comprising one or more optional ingredients selected from the group consisting of amino acids, anesthetics, anti-acne agents, anti-allergenics, antifungals, antimicrobials, anti-inflammatory agents, anti-irritants, antioxidants, antiseptics, antivirals, chelating agents, colorants, hyperpigmenting agents, self-tanning agents, emollients, emulsifiers, exfoliants, film formers, fragrances, humectants, hypopigmenting agents, insect repellents, lubricants, moisturizers, pharmaceutical agents, peptides, vitamins and vitamin derivatives, photostabilizing agents, preservatives, retinoids, skin protectants, skin penetration enhancers, staining agents, sunscreens, stabilizers, surfactants, thickeners, viscosity and/or rheology modifiers, and any combinations thereof.
15 . A method for inhibiting the induced lipid synthesis in skin, comprising: topically applying to the skin a composition having a cosmetically acceptable vehicle and an effective amount of carnitine creatinate.
16 . The method of claim 15 , wherein the carnitine creatinate is present at about 0.01 wt % to about 25 wt % based on the total weight of the composition.
17 . A method for inhibiting the formation of cellulite in skin, comprising: topically applying to the skin a composition having a cosmetically acceptable vehicle and an effective amount of carnitine creatinate.
18 . The method of claim 17 , wherein the carnitine creatinate is present at about 0.01 wt % to about 25 wt % based on the total weight of the composition.Join the waitlist — get patent alerts
Track US2006134147A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.